• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量子光学免疫分析:基于上转换纳米颗粒的新冠病毒中和分析

Quantum Optical Immunoassay: Upconversion Nanoparticle-based Neutralizing Assay for COVID-19.

作者信息

Rajil Navid, Esmaeili Shahriar, Neuman Benjamin W, Nessler Reed, Wu Hung-Jen, Yi Zhenhuan, Brick Robert W, Sokolov Alexei V, Hemmer Philip R, Scully Marlan O

机构信息

Institute for Quantum Science and Engineering, Texas A&M university, TX 77843, US.

Department of Biology, Texas A&M University, College Station, TX 77843, US.

出版信息

ArXiv. 2021 Oct 13:arXiv:2110.06755v1.

PMID:34671697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8528078/
Abstract

In a viral pandemic, a few important tests are required for successful containment of the virus and reduction in severity of the infection. Among those tests, a test for the neutralizing ability of an antibody is crucial for assessment of population immunity gained through vaccination, and to test therapeutic value of antibodies made to counter the infections. Here, we report a sensitive technique to detect the relative neutralizing strength of various antibodies against the SARS-CoV-2 virus. We used bright, photostable, background-free, fluorescent upconversion nanoparticles conjugated with SARS-CoV-2 receptor binding domain as a phantom virion. A glass bottom plate coated with angiotensin-converting enzyme 2 (ACE-2) protein imitates the target cells. When no neutralizing IgG antibody was present in the sample, the particles would bind to the ACE-2 with high affinity. In contrast, a neutralizing antibody can prevent particle attachment to the ACE-2-coated substrate. A prototype system consisting of a custom-made confocal microscope was used to quantify particle attachment to the substrate. The sensitivity of this assay can reach 4.0 ng/ml and the dynamic range is from 1.0 ng/ml to 3.2 {\mu}g/ml. This is to be compared to 19 ng/ml sensitivity of commercially available kits.

摘要

在病毒性大流行期间,为成功控制病毒并降低感染的严重程度,需要进行一些重要检测。在这些检测中,抗体中和能力检测对于评估通过疫苗接种获得的群体免疫力以及检测用于对抗感染的抗体的治疗价值至关重要。在此,我们报告一种灵敏的技术,用于检测各种抗体针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的相对中和强度。我们使用与SARS-CoV-2受体结合域偶联的明亮、光稳定、无背景的荧光上转换纳米颗粒作为模拟病毒粒子。涂有血管紧张素转换酶2(ACE-2)蛋白的玻璃底板模拟靶细胞。当样品中不存在中和性IgG抗体时,颗粒将以高亲和力结合到ACE-2上。相反,中和抗体可阻止颗粒附着到涂有ACE-2的底物上。使用由定制共聚焦显微镜组成的原型系统来量化颗粒与底物的附着情况。该检测方法的灵敏度可达4.0 ng/ml,动态范围为1.0 ng/ml至3.2 μg/ml。相比之下,市售试剂盒的灵敏度为19 ng/ml。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/6a79d07f337b/nihpp-2110.06755v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/b652e77b101c/nihpp-2110.06755v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/0c4f6bba1e48/nihpp-2110.06755v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/6a79d07f337b/nihpp-2110.06755v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/b652e77b101c/nihpp-2110.06755v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/0c4f6bba1e48/nihpp-2110.06755v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f0/8528078/6a79d07f337b/nihpp-2110.06755v1-f0003.jpg

相似文献

1
Quantum Optical Immunoassay: Upconversion Nanoparticle-based Neutralizing Assay for COVID-19.量子光学免疫分析:基于上转换纳米颗粒的新冠病毒中和分析
ArXiv. 2021 Oct 13:arXiv:2110.06755v1.
2
Quantum optical immunoassay: upconversion nanoparticle-based neutralizing assay for COVID-19.量子光学免疫分析:基于上转换纳米粒子的 COVID-19 中和分析。
Sci Rep. 2022 Jan 24;12(1):1263. doi: 10.1038/s41598-021-03978-2.
3
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.接种疫苗人群中 SARS-CoV-2 病毒中和抗体滴度与刺突抗体和 ACE2 抑制的相关性。
Microbiol Spectr. 2022 Oct 26;10(5):e0131522. doi: 10.1128/spectrum.01315-22. Epub 2022 Sep 19.
4
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay.利用竞争性化学发光免疫分析技术,可在数分钟内自动检测 SARS-CoV-2 中和抗体。
Anal Bioanal Chem. 2023 Jan;415(3):391-404. doi: 10.1007/s00216-022-04416-6. Epub 2022 Nov 8.
5
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.化学发光免疫分析检测疫苗接种和康复 COVID-19 队列中中和抗体和结合抗体的纵向分布。
Immun Inflamm Dis. 2022 Jun;10(6):e612. doi: 10.1002/iid3.612.
6
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
7
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
8
A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity.一种高灵敏度的基于珠粒的流式细胞术竞争结合分析,用于检测 SARS-CoV-2 中和抗体活性。
Front Immunol. 2022 Nov 30;13:1041860. doi: 10.3389/fimmu.2022.1041860. eCollection 2022.
9
Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.三种定量抗 SARS-CoV-2 抗体免疫分析方法的评估。
Microbiol Spectr. 2021 Dec 22;9(3):e0137621. doi: 10.1128/spectrum.01376-21.
10
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.使用商业酶联免疫吸附试验和化学发光免疫分析方法推断住院 COVID-19 患者血清中 SARS-CoV-2 刺突结合中和抗体效价。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):485-494. doi: 10.1007/s10096-020-04128-8. Epub 2021 Jan 6.

本文引用的文献

1
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.mRNA-1273疫苗诱导的针对SARS-CoV-2变体的抗体的持久性。
Science. 2021 Sep 17;373(6561):1372-1377. doi: 10.1126/science.abj4176. Epub 2021 Aug 13.
2
Neutralizing monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的中和单克隆抗体。
Nat Rev Immunol. 2021 Jun;21(6):382-393. doi: 10.1038/s41577-021-00542-x. Epub 2021 Apr 19.
3
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
4
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.SARS-CoV-2 变异株对单克隆和血清来源的多克隆抗体中和作用的抗性。
Nat Med. 2021 Apr;27(4):717-726. doi: 10.1038/s41591-021-01294-w. Epub 2021 Mar 4.
5
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.mRNA 疫苗诱导的针对 SARS-CoV-2 和循环变异株的抗体。
Nature. 2021 Apr;592(7855):616-622. doi: 10.1038/s41586-021-03324-6. Epub 2021 Feb 10.
6
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.一种使用 SARS-CoV-2 刺突蛋白受体结合域的 SpyCatcher 多聚化的 COVID-19 疫苗候选物诱导产生了强烈的中和抗体反应。
Nat Commun. 2021 Jan 22;12(1):542. doi: 10.1038/s41467-020-20654-7.
7
Comparison of Rapid Antigen Tests for COVID-19.COVID-19 的快速抗原检测比较。
Viruses. 2020 Dec 10;12(12):1420. doi: 10.3390/v12121420.
8
Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2.增强侧流分析法的灵敏度及其在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测中的应用
Appl Phys Lett. 2020 Sep 21;117(12):120601. doi: 10.1063/5.0021842.
9
Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA.基于纸基 ELISA 的 SARS-CoV-2 人源化抗体检测。
Analyst. 2020 Nov 23;145(23):7680-7686. doi: 10.1039/d0an01609h.
10
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.硕果累累的中和抗体研发管线为抗击 SARS-CoV-2 带来希望。
Trends Pharmacol Sci. 2020 Nov;41(11):815-829. doi: 10.1016/j.tips.2020.07.004. Epub 2020 Jul 31.